5318-27-4Nc1ccc2cc[nH]c2c1MIMYTSWNVBMNRH-UHFFFAOYSA-N5318-27-4DTXSID30292416Warning
H302 (97.9%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 47 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
UsesReactant for preparation of:Inhibitors of mammalian target of rapamycin (mTOR ) proteinInhibitors of the AcrAB-TolC efflux pumpInhibitors of Gli1-mediated transcription in the Hedgehog pathwayPotent DNA-topoisomerase II poisons and anti-MDR agentsProtein kinase C θ (PKCθ) inhibitorsPiperidine carboxamide as transient receptor potential cation channel subfamily V member 1 (TRPV1) antagonistsPotent and selective blockers of the Nav1.8 sodium channel as potential analgesics for the treatment of neuropathic and inflammatory pain5,6-fused heteroaromatic ureas as TRPV1 antagonistsAllosteric enhancers of the A3 adenosine receptorHuman liver glycogen phosphorylase (HLGP) inhibitors for the treatment of type 2 diabetes
Loading…